Pyrazole derivatives as 11-beta-HSD1 inhibitors

Details for Australian Patent Application No. 2008215976 (hide)

Owner AstraZeneca AB

Inventors Packer, Martin John; Whittamore, Paul Robert Owen; Stocker, Andrew; Scott, James Stewart

Agent Davies Collison Cave

Pub. Number AU-B-2008215976

PCT Pub. Number WO2008/099145

Priority 60/889,336 12.02.07 US; 60/985,735 06.11.07 US

Filing date 11 February 2008

Wipo publication date 21 August 2008

Acceptance publication date 24 November 2011

International Classifications

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 231/18 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/099145 Priority application(s): WO2008/099145

24 November 2011 Application Accepted

  Published as AU-B-2008215976

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008215979-Production of Lentiviral Vectors

2008215971-Scaffold with increased pore size